Panacro Announces Professor Chow Shein-Chung from Duke University Joining as Chief Consulting Scientist

Collaboration with Sponsor 丨 IND Application for Recombinant HPV15 (Escherichia coli) Co-developed by Chengda Biologics & BHGB Approved

New Year wishes from Chairman

Beijing Pancro participated in the collaborative innovation Alliance of Medical research in northern Anhui and attended the launching meeting

Collaboration with Sponsor 丨Clinical Trial of Fudan Zhangjiang Obeticholic Acid Tablets for Primary Biliary Cholangitis Treatment Completes First Subject Enrollment

Training of “Empowering The Managers” by Panacro (2nd session)

Collaboration with Sponsor 丨 Bebetter Med HDAC/PI3K Dual-target Inhibitor BEBT-908 Proposed for Inclusion in Breakthrough Therapy List

Collaboration with Sponsor 丨Binhui Biopharm BS001 injection is highly effective in treating melanoma

Collaboration with Sponsor 丨 PD-1 NDA by Lepu Biopharma Accepted by CDE

Beijing Panacro joins in Northern Anhui Alliance for Collaborative Medical Research & Innovation and attends the kick-off meeting